LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

Search

Cogent Biosciences Inc

Închisă

4.82 -2.63

Rezumat

Modificarea prețului

24h

Curent

Minim

4.71

Maxim

4.95

Indicatori cheie

By Trading Economics

Venit

-4.1M

-72M

EPS

-0.525

Angajați

205

EBITDA

-1.2M

-74M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+229.9% upside

Dividende

By Dow Jones

Următoarele câștiguri

5 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-67M

567M

Deschiderea anterioară

7.45

Închiderea anterioară

4.82

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Cogent Biosciences Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

23 mai 2025, 20:33 UTC

Achiziții, Fuziuni, Preluări

Salesforce in Talks to Buy Informatica, Bloomberg Reports, Citing Sources

23 mai 2025, 21:57 UTC

Acțiuni populare

Stocks to Watch: Apple, Booz Allen, Constellation Energy, Intuit -- WSJ

23 mai 2025, 21:15 UTC

Top știri

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23 mai 2025, 21:04 UTC

Achiziții, Fuziuni, Preluări

Real-Estate Broker Douglas Elliman Could See Takeover Battle After Report of Bid -- Barrons.com

23 mai 2025, 20:56 UTC

Top știri
Achiziții, Fuziuni, Preluări

Salesforce Back in Deal Talks With Informatica -- WSJ

23 mai 2025, 20:51 UTC

Top știri

Boeing in Tentative Agreement to Pay $1.1 Billion to Avoid Trial for 737 MAX Crashes -- WSJ

23 mai 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

23 mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

23 mai 2025, 20:41 UTC

Top știri

Stocks Fall on Tariff Broadside, After Week of Bond Market Agita -- WSJ

23 mai 2025, 20:28 UTC

Top știri

Trump Threatens EU With 50% Tariffs, Takes Aim at Apple; Nasdaq Drops -- WSJ

23 mai 2025, 20:06 UTC

Top știri

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 5th Update

23 mai 2025, 20:06 UTC

Achiziții, Fuziuni, Preluări

Salesforce Stock Drops, Informatica Soars. A Deal May Be Back on the Table. -- Barrons.com

23 mai 2025, 19:50 UTC

Top știri

Trump's Tariffs: Where Things Stand -- 16th Update

23 mai 2025, 19:28 UTC

Achiziții, Fuziuni, Preluări

Trump on Truth Social: 'Bulk of That Investment Will Occur in the Next 14 Months'

23 mai 2025, 19:28 UTC

Achiziții, Fuziuni, Preluări

Trump on Truth Social: 'This Will Be a Planned Partnership Between United States Steel and Nippon Steel'

23 mai 2025, 19:27 UTC

Achiziții, Fuziuni, Preluări

Trump on Truth Social: 'Proud to Announce That, After Much Consideration and Negotiation, US Steel Will REMAIN in America'

23 mai 2025, 19:20 UTC

Market Talk

Crude Futures Post Modest Weekly Losses -- Market Talk

23 mai 2025, 19:18 UTC

Market Talk

U.S. Natural Gas Futures End Week Unchanged -- Market Talk

23 mai 2025, 18:57 UTC

Top știri

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23 mai 2025, 18:54 UTC

Top știri

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- Update

23 mai 2025, 18:53 UTC

Top știri
Achiziții, Fuziuni, Preluări

McDonald's Bids Goodbye to CosMc's, Its Space Alien-Themed Spinoff -- WSJ

23 mai 2025, 18:52 UTC

Achiziții, Fuziuni, Preluări

DDC Enterprise Issues 254,333 Class A Ordinary Shrs in Exchange for 21 BTC, Valued at About $2.28M in Current Market Price

23 mai 2025, 18:13 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

23 mai 2025, 18:13 UTC

Market Talk

Gold Trades Higher on Reminder of Risk -- Market Talk

23 mai 2025, 18:00 UTC

Top știri

Apple's Stock Still Not Pricing in Trump's Demands - Heard on the Street -- WSJ

23 mai 2025, 17:51 UTC

Market Talk
Câștiguri

Workday Sees Higher Bar for Guidance -- Market Talk

23 mai 2025, 17:42 UTC

Top știri

Dow Drops, Trump Threatens EU With 50% Tariffs, Takes Aim at Apple -- WSJ

23 mai 2025, 17:39 UTC

Market Talk

U.S. Oil Rig Count Falls to Lowest Level Since November 2021 -- Market Talk

23 mai 2025, 17:07 UTC

Top știri

Trump's Tariffs: Where Things Stand -- 15th Update

23 mai 2025, 17:04 UTC

Market Talk
Câștiguri

Workday Appears to Have Upside Potential on Conservative Outlook -- Market Talk

Comparație

Modificare preț

Cogent Biosciences Inc Așteptări

Obiectiv de preț

By TipRanks

229.9% sus

Prognoză pe 12 luni

Medie 16.33 USD  229.9%

Maxim 24 USD

Minim 7 USD

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCogent Biosciences Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

10 ratings

7

Cumpărare

3

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

4.88 / 5.87Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Weak Bearish Evidence

Termen lung

Strong Bearish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Cogent Biosciences Inc

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.